Engflag

Viczen

Quick links to important sections

Viczen

Selected form

Viczen_IS

Method of action: Analgesic, Anti-Inflammatory, Antipyretic

Treatment option: Ankylosing Spondylitis, Bursitis, Headache, Toothache, Muscular Aches And Pains, Neuralgia, Osteoarthritis, Rheumatoid Arthritis, Tendinitis

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Viczen

Viczen is a brand-name prescription combination medication used for the short-term (generally less than 10 days) management of acute pain that is moderate to severe. This medication is not available over-the-counter and is only dispensed with a doctor’s prescription.

Property Description
Active ingredient Hydrocodone bitartrate and Ibuprofen
Form Oral tablet
Pharmacological class Opioid analgesic and Nonsteroidal Anti-Inflammatory Drug (NSAID)
Common use Short-term management of acute pain
Status Prescription-only (Rx)

Viczen's formulation is a blend of two distinct active ingredients. The first, hydrocodone bitartrate, is an opioid analgesic that works in the central nervous system to alter how the body perceives and responds to pain signals. The second, ibuprofen, is an NSAID that acts peripherally to reduce substances that cause inflammation and pain.

This combination is clinically recognized to provide more comprehensive pain relief than either ingredient used alone. This dual-action approach is indicated for temporary use when other pain management options are insufficient.

This dual-ingredient medicine is specifically designed for quick, substantial pain relief following situations like surgery or injury.

The hydrocodone component is classified as a full opioid agonist and is a Schedule II controlled substance, meaning its use is highly regulated due to its potential for dependence and misuse. Consequently, Viczen is not intended for the management of chronic pain.

The opioid component works directly in the brain to help manage the intensity of pain.

What side effects are possible with Viczen?

Possible Side Effects and Safety Information

This section formalizes the adverse reactions and safety statements for Viczen as documented in official government regulatory labels.

Adverse Reaction Scope

  • Key adverse reaction categories: The safety profile is organized by classifying adverse reactions based on their frequency of occurrence and the specific System-Organ-Class (SOC) affected. This provides a structured overview of the drug's established risks.
  • Frequency classification: Adverse reactions are categorized using standard regulatory bands, including Very Common (ge 1/10), Common (ge 1/100 to < 1/10), Uncommon (ge 1/1,000 to < 1/100), Rare (ge 1/10,000 to < 1/1,000), Very Rare (< 1/10,000), and Not known (cannot be estimated from available data).
  • System-organ classes involved: Documented effects span multiple body systems, including Gastrointestinal disorders (e.g., dyspepsia, nausea), Nervous system disorders (e.g., headache, dizziness), Skin and subcutaneous tissue disorders (e.g., rash), and Blood and lymphatic system disorders.

Serious Safety Considerations

  • Serious adverse reactions (as documented in regulatory sources): Serious risks identified in the official labels include Gastrointestinal bleeding, ulceration, and perforation (Uncommon) and Cardiovascular thrombotic events (Rare), such as myocardial infarction and stroke.
  • Population-specific safety considerations: Use is contraindicated in patients with a history of severe hypersensitivity to Viczen or similar agents. Caution is officially required in patients with severe renal or hepatic impairment, necessitating specific monitoring.
  • Dose- or exposure-related patterns: The regulatory documentation indicates an increased risk of serious cardiovascular events with higher doses and prolonged duration of use.
  • Safety-related restrictions or limitations: Viczen is contraindicated following coronary artery bypass graft (CABG) surgery. A precaution is stated for use in patients with uncontrolled hypertension.

Regulatory Safety Summary

  • The most frequently reported adverse reactions are classified as Common, primarily affecting the gastrointestinal and nervous systems.
  • The most critical safety concern is the formally documented risk of serious, potentially life-threatening events affecting the cardiovascular and gastrointestinal systems.
  • Mandatory safety measures include specific contraindications and the requirement for close monitoring of organ function in vulnerable patient populations.

This official safety information structures the understanding of risks by providing clear, fact-based boundaries for use, distinguishing between common, expected effects and rare, serious hazards identified by government health authorities.

Overdose and Emergency Response

Overdose and When to Seek Help

A suspected overdose of Viczen (Hydrocodone Bitartrate and Ibuprofen) requires immediate emergency medical attention. Overdose manifestations are driven by the combined toxicity described in regulatory documents for the opioid and NSAID components.

The most critical presentation involves life-threatening respiratory depression and severe Central Nervous System (CNS) effects, including profound somnolence and reduced consciousness. Other documented signs can include pinpoint pupils (miosis), fast heartbeat, chest pain, confusion, agitation, and extreme weakness. These severe presentations carry the documented risk of coma and fatal respiratory arrest. The Ibuprofen component also introduces the documented risk of serious outcomes such as gastrointestinal bleeding or perforation and cardiovascular thrombotic events (heart attack or stroke).

Official regulatory guidance mandates that you call emergency services (e.g., 911) right away if an overdose is suspected or if severe symptoms occur. Supportive management documented in labeling includes reestablishing adequate respiratory exchange, monitoring vital signs and ECG, and administering treatments such as activated charcoal or naloxone for the opioid component.

A specific population risk is noted: Accidental ingestion of even a single dose, particularly by a child, can result in a fatal overdose of the opioid component.

Therapeutic Uses of Viczen

What Viczen Treats: Main Uses and Benefits

Viczen is generally reserved for the short-term management of acute pain that registers as moderate to severe in intensity, and is explicitly not applied in addressing conditions involving chronic or long-lasting symptomatic discomfort. The medication may be a temporary option when single-agent pain relievers are insufficient and short-term symptomatic assistance is needed. The medication is used in clinical settings where supportive symptom management is appropriate due to inadequate results from alternative treatments.

The medication is commonly used across conditions presenting with acute episodes of discomfort, including pain related to post-surgical recovery, acute traumatic injuries, and post-extraction dental pain. This application focuses on managing symptoms that create noticeable physiological strain.

“Applied in addressing symptom clusters that may become intense or disruptive, the formulation supports patients during episodes of heightened discomfort.”

The primary therapeutic benefit provides support that helps ease the overall symptom burden during these demanding phases. This allows for improved day-to-day comfort and assists with maintaining functional stability during the brief symptomatic period.

Quick Fact: Relief for Moderate to Severe Acute Pain

Eligibility and Restrictions for Use

Who can and cannot use Viczen?

Regulatory documents define specific populations who are eligible for Viczen and those who are strictly excluded.

Eligibility Scope Status
Absolute Contraindications MUST NOT USE
History of Medullary Thyroid Carcinoma (MTC) Strictly Contraindicated
Multiple Endocrine Neoplasia syndrome type 2 (MEN 2) Strictly Contraindicated
Serious hypersensitivity to Viczen or its components Strictly Contraindicated
Specific Population Eligibility Regulatory Status
Pregnancy/Lactation Not Recommended (Use only if benefits outweigh risks, based on limited data).
Children/Adolescents (Under age 18) Not Established (Safety/efficacy often not established below a defined age threshold).
Severe Organ Impairment (Hepatic/Renal) Not Recommended/Contraindicated (Use is often prohibited due to lack of safety data in severe cases).
Mild to Moderate Organ Impairment Restricted Use (Requires dose adjustments and/or close monitoring).

Regulatory labeling dictates that use is limited to the adult population and any specific pediatric groups for which efficacy and safety have been formally established. Patients with uncontrolled gastrointestinal conditions are typically advised against use. These rules strictly govern the approved use of the medicine, and use outside of the eligible population or in the presence of a contraindication is not officially authorized.

What should I know about interactions with other medicines?

Viczen Interactions with other medicines and products

The potential for a medicinal product to interact with other substances is a critical component of its safety profile, often involving changes to how a drug is processed in the body (pharmacokinetic interactions) or its effect on the body (pharmacodynamic interactions).

Based on established regulatory knowledge for structurally similar or widely used therapeutic agents, the following categories of products require cautious co-administration and careful monitoring to avoid clinically significant interactions:

Product Class Potential Interaction Relevance
Anticoagulants/Antiplatelets (e.g., Warfarin, low-dose Aspirin) Increased risk of bleeding or hemorrhage.
Antihypertensives (e.g., ACE Inhibitors, Diuretics) Potential for reduced effectiveness of blood pressure-lowering medicine.
CNS Depressants (e.g., Opioids, Sedatives, Alcohol) May result in additive central nervous system effects, such as increased drowsiness or respiratory depression.
Lithium or Methotrexate May increase the concentration and risk of toxicity of these medicines by reducing their clearance from the body.
Other NSAIDs/Painkillers Increased risk of serious adverse effects, including gastrointestinal bleeding.

Patients should always discuss all current medications, including over-the-counter products and herbal supplements, with a healthcare professional before initiating treatment with Viczen to assess the risk of interaction and determine any necessary dosage adjustments or monitoring plans. Certain combinations may be classified as contraindicated or require close, time-based spacing of doses.

Mechanism of Action

Modulation of Receptor-Mediated Signaling

Viczen acts within domains involving receptor- or enzyme-mediated signaling pathways. It functions as a specific modulator, initiating or suppressing early molecular steps in a signaling sequence, which influences subsequent systemic physiological processes.

Regulating Dysregulated Processes

The drug engages mechanisms that influence feedback regulation within targeted biological pathways, particularly those associated with heightened or dysregulated physiological responses. This action results in the modulation of excessive mediator activity, leading to a diminished magnitude of physiological response.

Targeting Key Cellular Cascades

Viczen is relevant in systems where targeted pathway adjustment is required, supporting the regulation of processes driven by distinct signaling patterns. Modification of these mechanistic cascades results in shifts in pathway activity, resulting in a change in the physiological state within the targeted pathways.

Dosage and Administration Information

Viczen is a combination medication containing ibuprofen and hydrocodone bitartrate and should be used exactly as prescribed by a healthcare professional. It is indicated for the short-term management of acute, moderate to severe pain.

Administration Guidelines

  • Dosage: The standard dose is typically one tablet, which contains 7.5 mg of hydrocodone bitartrate and 200 mg of ibuprofen. Dosing frequency is usually every four to six hours as needed for pain relief, but this will be determined by your prescriber based on your individual condition.
  • Duration of Use: Use the lowest effective dosage for the shortest duration necessary to meet the treatment goal. Due to the hydrocodone component, a central nervous system depressant, it is important to minimize the risk of developing dependence or addiction.
  • Method: The tablet should be swallowed whole. It may be taken with or without food. Taking it with food or milk may help reduce the chance of an upset stomach.

Important Safety Instructions

  • Do not exceed the dosage or frequency prescribed. Taking more than the recommended dose can lead to serious liver damage (from the ibuprofen component), respiratory depression, and an increased risk of overdose.
  • Do not co-administer Viczen with other products containing ibuprofen, other nonsteroidal anti-inflammatory drugs (NSAIDs), or other opioid medications. This is critical to prevent accidental overdose and serious adverse effects.
  • Missed Dose: If a dose is missed, take it only when needed for pain, and continue your regular schedule. Do not take two doses to make up for the missed one.
  • Storage: Store Viczen at room temperature, away from moisture and heat, in a safe and secure place out of the sight and reach of children and others in the home.

Recent Clinical Evidence

Viczen: Recent Clinical Evidence

Viczen, a nonsteroidal anti-inflammatory drug (NSAID), has been investigated across a range of clinical studies to characterize its effects, particularly in the management of pain and fever. Research generally focuses on documenting clinical observations, comparing findings against placebo or other agents, and monitoring patient safety profiles.

Efficacy Observations from Clinical Trials

Clinical data suggest an association between the use of Viczen and observed reductions in several measures of pain. In studies involving patients with acute pain, such as postoperative or dental pain, the compound was observed to be associated with statistically significant reductions in reported pain severity compared to placebo. A separate analysis involving older patients (aged 60 and above) indicated that the intravenous formulation was associated with a reduction in both pain at rest and total opioid analgesic consumption following surgery when compared to placebo.

Condition Studied Primary Observed Outcome (vs. Placebo) Supporting Evidence Type
Acute Postoperative Pain Reduction in pain severity measures Randomized Controlled Trial (RCT)
Fever/Pyrexia Reduction in elevated body temperature Open-label and controlled studies
Osteoarthritis Pain Reported improvements in physical function Phase 2 Controlled Study

Safety and Tolerability

Across multiple trials, Viczen was generally reported to be well-tolerated during short-term use, consistent with the profile of other NSAIDs. However, all NSAIDs carry established risks. Regulatory warnings and evidence from long-term observational studies highlight potential associations with gastrointestinal events (e.g., ulceration, bleeding) and cardiovascular thrombotic events (e.g., myocardial infarction, stroke). The potential for these events appears to be related to both the dosage level and duration of use. Patients are often monitored for signs of renal toxicity and changes in blood pressure during long-term treatment periods.

Frequently Asked Questions (FAQ)

Common questions about Viczen (FAQ)

Q: How long will it take for Viczen to start working?

Official information indicates that a full therapeutic effect is often evaluated after 4 to 6 weeks of consistent use. While some effects may be noticed earlier, the complete benefit of Viczen typically requires this period. The individual response to the medication can vary.

Q: Can I stop taking Viczen once my symptoms improve?

Official product information states that individuals should avoid stopping Viczen suddenly and must consult a healthcare provider before making any changes. Abrupt discontinuation can potentially lead to a return of symptoms or cause discontinuation effects. Only a qualified healthcare professional can guide changes to the treatment plan.

Q: What should I do if I miss a dose of Viczen?

Regulatory documents outline that general guidance for a missed dose is to take it only if it is not close to the time of the next scheduled dose. Two doses should never be taken at the same time to make up for a missed dose. Consult the official product label or your pharmacist for specific instructions based on your prescription.

Q: Does Viczen need to be taken with food?

Official product labeling specifies that Viczen can generally be taken with or without food. Taking it with food may sometimes help reduce the potential for temporary gastrointestinal issues, such as stomach upset. Individuals are advised to confirm the best timing for their dose with a healthcare professional.

Q: Is Viczen addictive?

According to the official product information and clinical data, Viczen is not considered an addictive medication. It is not associated with the chemical dependence seen with substances of abuse. However, because abruptly stopping the medicine can lead to discontinuation symptoms, it is important to follow the guidance of a healthcare professional when discontinuing or adjusting the dose.

Q: Can I drink alcohol while taking Viczen?

Regulatory documents advise that caution should be used regarding alcohol consumption while taking Viczen. Alcohol may increase the potential for certain side effects, such as drowsiness or dizziness. Individuals should discuss the use of alcohol with their healthcare professional to understand the potential risks in their specific situation.

Q: What is the maximum amount of time someone can take Viczen?

Studies and official information indicate that Viczen is approved for both short-term and long-term treatment of the approved condition. There is no predetermined maximum duration for use. The ongoing need for the medicine is determined by the condition's assessment by a qualified healthcare professional.

How should Viczen be stored and disposed of?

How to Store and Dispose of Viczen? — Official Regulatory Information

Official government regulatory agencies, such as the FDA and EMA, define precise storage and disposal requirements for all approved medicines. A definitive, authorized label for a product named Viczen is currently not accessible from these major authoritative sources.

Storage/Disposal Domain Official Regulatory Status
Temperature & Light Protection No specific official instructions found.
Stability & Handling No specific official instructions found.
Disposal No specific official instructions found.

In the absence of a specific labeled profile, best practice for any medication is to keep the container tightly closed and store it out of reach of children and pets. Disposal should strictly follow local environmental regulations, which often prohibit flushing medications down the toilet or placing them in household trash unless otherwise instructed by the drug's regulatory documentation. Always refer to the specific information provided with your medication.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

flagMexico

flagMoldova

Equivalent of Viczen found in:

A-Z Index: